Wincal Biopharm Company Profile: Valuation, Funding & Investors

Wincal Biopharm Company Profile: Valuation, Funding & Investors

4.7
(758)
Bewertung schreiben
Mehr
€ 28.99
In den Warenkorb
Auf Lager
Beschreibung

Financial Model analyzing a Biopharmaceutical Company using a Risk-Adjusted NPV Valuation Methodology.

Pharma Biotech Financial Model incl. Risk-Adjusted DCF and VC Valuation

Pharma Biotech Valuation Model Template

WinZO - Funding, Financials, Valuation & Investors

Vimcal - Crunchbase Company Profile & Funding

Pharma Biotech Financial Model Template

IMS2023 Program Book by Kiefer Creative - Issuu

EraCal - Crunchbase Company Profile & Funding

Vimcal - Crunchbase Company Profile & Funding

Vimcal raises $4.5 million to expand its team offerings

Biopharm, Wincal Biopharm

Financial Model analyzing a Biopharmaceutical Company using a Risk-Adjusted NPV Valuation Methodology.

Pharma Biotech Financial Model incl. Risk-Adjusted DCF and VC Valuation

Vimcal raises $4.5 million to expand its team offerings

IMS2023 Program Book by Kiefer Creative - Issuu

Should You Buy Bio-Rad Laboratories Stock After Its 50% Fall This Year?

Pharma Biotech Valuation Model Template